Thursday 8 May 2014, 12.30PM to 1.30pm
Speaker(s): Adam Smith, PhD. KTP Associate/Senior Research Fellow at York Health Economics Consortium Ltd
Abstract: The EQ-5D is a widely used in oncology clinical trials to assess patients' health-related quality of life and for cost-effectiveness calculations. Despite the popularity of the measure there is conflicting evidence in terms of its use in oncology. The talk will draw together the results from a systematic review of the responsiveness of the EQ-5D, as well as a number of empirical studies. The results will conclude that the EQ-5D is not fit for purpose in oncology.
Location: Room A/E/W/104
Who to contact
For more information on these seminars, contact:
- Ana Duarte
ana.duarte@york.ac.uk- James Lomas
james.lomas@york.ac.uk
Economic evaluation seminar dates
- 10 December 2014
Claire Hulme, Professor of Health Economics, University of Leeds